A new statistical data titled as Global Neuromonitoring Devices Market Research Report (2021-2030) has been published by Absolute Markets Insights. Different features of recent trends have been elaborated to give an in-depth analysis of the progress of the industries. Effective exploratory techniques such as qualitative and quantitative analysis have been used to discover the accurate data.
For the effective business outlook, it studies different global regions, such as North America, Latin America, Asia-Pacific, Japan, and India by considering different segments such as type, size, as well as applications. SWOT and Porter’s Five analysis have been used to analyze the informative data such as cost, prices, revenue, and end-users. This research report has been aggregated on the basis of various attributes such as manufacturing base, products or services and raw material to understand the requirements of the businesses.
Apart from the regional outlook, it throws light on leading industry key players such as Cadwell Industries Inc., inomed Medizintechnik GmbH, Integra LifeSciences, Medtronic, Moberg Research Inc., Natus Medical, Neurosoft, Neurostyle, Neurovision Medical Products, and Nihon Kohden Corporation to understand the successful sales strategies of the businesses. Additionally, it covers various factors which is responsible for the progress of the market. For better understanding of ups-down stages of the businesses, analysts also focus on various attributes are limiting the growth of the industries. This comprehensive data provides the guidelines to discover the global opportunities for the Neuromonitoring Devices sector in the near future.
Browse the full report description, along with the ToCs and List of Facts and Figures @ https://www.absolutemarketsinsights.com/reports/Neuromonitoring-Devices-Market-2021---2029-895
In terms of revenue, neuromonitoring devices market was valued at US$ 7022.33 Mn in 2020 growing at a CAGR of +6.8% over the forecast period (2021 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
The biggest driver for the growth of global neuromonitoring devices market is the need for better risk management during complex surgical procedures. Hence, the use of intraoperative neuromonitoring during a surgical procedure helps surgeons to reduce the risks of impairment to neurophysiological relevant nerve structures. It also prevents the possible impairment of nerve function which might happen due to improper positioning of the patient. High rates of neurological disorders due to various factors such as changes in the social environment, increased stress levels, and lifestyle changes is the second major factor creating demand and thus, advancing the growth of neuromonitoring devices market. Other factors supporting the market growth include increasing postoperative risks of cerebrovascular disorders and increased demand for automated neurological monitoring devices in hospitals. In July 2021, NuVasive received Conformité Européenne (CE) mark for Pulse platform. Global clinical evaluations started in many countries after that. The latest design update makes Pulse a platform to assist surgeons in all spine surgery-related procedures. The shortage of professionals trained to operate neurological monitoring devices is the biggest restraint in the global neuromonitoring devices market growth. This problem is higher in developing countries, where technological knowhow is less. However, this may change in the future because of various companies spending heavily on the training of medical professionals and efforts of many governments to increase the role of technology in the field of medicine can boost the global neuromonitoring devices market in future.
Technological advancement enabling the development of non-invasive devices and minimally invasive devices is anticipated to advance the growth of global neuromonitoring devices market over the forecast period. According to the U.S. Centers for Disease Control and Prevention (CDC), in the USA, about 4,600 adult day service centers offered long-term care services for assisted living and similar residential care communities in 2016. Same could be said for 4,300 hospice care facilities, 12,200 home health agencies, 15,600 nursing homes, and 28,900. Such facilities always need to buy neuromonitoring devices. Hence, along with such facilities the market for neuromonitoring devices useful for home care can also increase in the near future, creating new opportunities for sales in order to cater new demands.
Global Neuromonitoring Devices Market: Report Scope
By Component
- Systems
- Accessories
- Stimulation Probe
- Tubes
- Electrodes
- Others
- Services
By Application
- Neurosurgery
- Spine Surgery
- Vascular Surgery
- Facial Nerve Surgery
- Rectal Surgery
- Colorectal Surgery
- Brain Mapping
- Thyroid Surgery
- Ear, Nose and Throat (ENT) Surgery
- Others
By End User
- Hospitals
- Ambulatory Surgical Centres
- Others
By Distribution Channel
- Direct
- Indirect
By Region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Contact Us:
Company: Absolute Markets Insights
Email id: sales@absolutemarketsinsights.com
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
Website: https://www.absolutemarketsinsights.com/